Please assess the completion status of the following clinical trial:

Trial Title: Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Based on medical history and previous examination, no gastrointestinal complaints can be defined~* Age between 18 and 65 years~* BMI between 18 and 25 kg/m2 and a weight of at least 50 kilograms~* Women in fertile age (\<55 years old) must use contraception or be postmenopausal for at least two years~Exclusion Criteria:~* History of severe or chronic cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological/psychiatric diseases, allergy, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol~* Use of medication, including vitamin and iron supplementation, except oral contraceptives, within 14 days prior to start of the study~* Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study~* Major abdominal surgery interfering with gastrointestinal function (uncomplicated appendectomy, cholecystectomy and hysterectomy allowed, and other surgery upon judgment of the principle investigator)~* Dieting (for example lactose-free, gluten-free, caloric-restrictive, vegetarian or vegan, macrobiotic diet)~* Pregnancy, lactation~* High alcohol consumption (\>15 alcoholic consumptions per week)~* Smoking/ Using drugs of abuse~* Self-admitted HIV-positive state~* Known allergic reaction to peppermint~* High intake of caffeine (\>8 cups coffee a day)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Tempocol-ColoPulse® (Type: EXPERIMENTAL): Tempocol-ColoPulse® is a colon-targeted-delivery peppermint oil capsule that will deliver peppermint oil in the (ileo-) colonic region specifically.
- Tempocol® (Type: ACTIVE_COMPARATOR): Tempocol® is an enteric-coated peppermint oil capsule that delivers peppermint oil in the upper small intestine.

Based on this trial design, predict the completion outcome and termination type (if applicable).